Global Acne Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Acne Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
Acne Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acne Drugs market is projected to reach US$ 4592.8 million in 2034, increasing from US$ 3616.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Teenagers and Adult are the major drivers for the industry.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acne Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, User and Regions Listed in the Report
Belli
Kate Somerville
Doudou Kang
Pikangwang
Cetaphil
Differin
Epiduo
ABSORICA
Eucerin
Kummel
BoardOfAcne
Tongrentang
CleaSkin
CBIC Clearasil
Segment by Type
Injection Acne Drugs
External Acne Drugs
Segment by User
Teenagers
Adult
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acne Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acne Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acne Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Acne Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product User, Volume and Revenue analysis of Each User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acne Drugs introduction, etc. Acne Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Acne Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Acne Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acne Drugs market is projected to reach US$ 4592.8 million in 2034, increasing from US$ 3616.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Teenagers and Adult are the major drivers for the industry.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acne Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, User and Regions Listed in the Report
By Company
Belli
Kate Somerville
Doudou Kang
Pikangwang
Cetaphil
Differin
Epiduo
ABSORICA
Eucerin
Kummel
BoardOfAcne
Tongrentang
CleaSkin
CBIC Clearasil
Segment by Type
Injection Acne Drugs
External Acne Drugs
Segment by User
Teenagers
Adult
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acne Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acne Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acne Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Acne Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product User, Volume and Revenue analysis of Each User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acne Drugs introduction, etc. Acne Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Acne Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices